Not checkedNot checked for notices yet.
<it>GSTT2 </it>promoter polymorphisms and colorectal cancer risk
Ahn Sun-A, Park Hye-Won, Kang Hio Chung and 7 more
BMC Cancer · 2007
doi:10.1186/1471-2407-7-16 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Glutathione <it>S</it>-transferases are a group of enzymes that participate in detoxification and defense mechanisms against toxic carcinogens and other compounds. These enzymes play an important role in human carcinogenesis. In the present study, we sought to determine whether <it>GSTT2 </it>promoter single nucleotide polymorphisms (SNPs) are associated with colorectal cancer risk.</p> <p>Methods</p> <p>A total of 436 colorectal cancer patients and 568 healthy controls were genotyped for three <it>GSTT2 </it>promoter SNPs (-537G>A, -277T>C and -158G>A), using real-time TaqMan assay and direct sequencing. An electrophoretic mobility shift assay (EMSA) was performed to determine the effects of polymorphisms on protein binding to the <it>GSTT2 </it>promoter.</p> <p>Results</p> <p>The -537A allele (-537G/A or A/A) was significantly associated with colorectal cancer risk (OR = 1.373, <it>p </it>= 0.025), while the -158A allele (-158G/A or A/A) was involved in protection against colorectal cancer (OR = 0.539, <it>p </it>= 0.032). Haplotype 2 (-537A, -277T, -158G) was significantly associated with colorectal cancer risk (OR = 1.386, <it>p </it>= 0.021), while haplotype 4 (-537G, -277C, -158A) protected against colorectal cancer (OR = 0.539, <it>p </it>= 0.032). EMSA data revealed lower promoter binding activity in the -537A allele than its -537G counterpart.</p> <p>Conclusion</p> <p>Our results collectively suggest that SNPs and haplotypes of the <it>GSTT2 </it>promoter region are associated with colorectal cancer risk in the Korean population.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.